Incidence rate of PPR in inspected flocks
Table 2 presents the prevalence rates of the inspected flocks in the study area. The overall morbidity and mortality rates in goats and sheep were 36.85% and 27.69% and 25.32% and 1.44%, respectively. The case fatality rates were 75.13% in goats and 5.69% in sheep. Analyses of mortality and morbidity rates - based upon vaccination status - revealed that the morbidity rates were higher for un-vaccinated flocks (56% for goats and 38% for sheep) (Table 3). Mortality rates were also higher in case of un-vaccinated flocks (42% for goats and 2% for sheep). No vaccinated animals were observed to be affected by the disease. In a previous study, there was a PPR outbreak in 1994 in a migratory sheep and goats which passed through the Uttarakhand state to Shimla in HP. In that outbreak, the percent morbidity and case fatality rate for sheep were 9.4 and 0, respectively whereas in goats the rates were 33 and 9.4, respectively
(Nanda et al., 1996). Mahajan et al., (2013) reported from Jammu region higher prevalence rate of PPR in goats (66.66%) than in sheep (35.71%).
Out of 6 flocks investigated, only 2 (flock Nos. 5 and 6) were vaccinated against PPRV, however, in flock No. 5, five kids showed clinical signs. The affected animals were less than six months old and not vaccinated.
Balamurugan et al., (2014) had reported that protective level antibody persisted up to 5 months only and suggested for vaccinating the lambs/kids at the age of 4 and 5 months, respectively. Therefore, the possible reason for the infection in 5 kids in the current study could be due to the lack of protective immunity.
Flock level economic losses due to PPR in HP
Component-wise per-animal losses due to PPR are given in Table 4 and 5, respectively for unvaccinated and combined flocks. The loss per animal was more when the same was calculated based on incidence rates in unvaccinated flocks. The per animal loss was INR 51.90 and INR 11.40 in case of goats and sheep, respectively. Per-animal loss based on incidence rates in combined flocks was INR 29.19 and INR 7.56, respectively in case of goats and sheep. The higher per head mortality loss (INR 33) in goats than that of sheep (INR 1.5) implies the significantly higher fatality in the former species. Lower case fatality ratio in sheep results in higher opportunity costs, which are costs of extra resources that are employed in care of diseased animals (INR 1.29 per head) as compared to the same for goats (INR 0.5).
Table 6 presents the proportional contribution of different components of the total loss. There were hardly any differences in the shares of different loss components to total losses, whether computed on the basis of unvaccinated or combined flocks. In case of goats, the greatest share (around 65%) of the total economic losses due to PPR were made up of mortalities, followed by losses due to reproductive failure (23%), direct loss in body weight (6%) and treatment cost (5%). In case of sheep, mortality losses accounted for a smaller share (14%) of total losses. The major component of losses for sheep was direct body weight losses (52%).
The study projected losses due to PPR incidence in small ruminant population at the state level. The estimation of state-level losses was carried out pertaining to three scenarios,
viz. outbreak incidence as observed in this study and 75% and 50% of outbreak incidence. Under high incidence scenario, the total loss due to PPR in HP was US$ 35.64 million with goats accounting for the overwhelming share of loss (US$ 29.54 million). Under moderate and low incidence rate assumptions, the total losses were estimated at US$ 26.73 million and US$ 18.07 million, respectively. The loss estimates as reported in published literature ranged between US$ 0.003 to 14.6 per head
(Opasina and Putt 1985; Thombare and Sinha 2009; Abubakar and Munir 2014).
Cost-Benefit Analysis of PPR control through vaccination
The BCR calculated was well over unity for both sheep and goats under all the scenarios,
viz. high, moderate and low incidence rates (Table 7), thus indicating that the benefits of vaccination outweigh the associated costs. The BCR ranged between 43:1 to 198:1, depending upon level of incidence rate assumptions and species. The BCR for all levels of incidence rates assumptions were higher for goats than sheep. This is on account of greater prevalence of the disease in goats. The BCR as calculated in this study are in line with
Bardhan et al., (2017b) who had reported a BCR of 123:1 for PPR control through vaccination using an economic surplus model.
There can be variations in many of the assumptions while calculating the returns to PPR control programme. In this context, sensitivity analysis was carried out to ascertain the effect of changes in two of the baseline assumptions. In the first scenario it was assumed that the vaccine has lower efficacy (50%) as compared to the baseline assumption. Given this pessimistic scenario, BCR decreased significantly (Fig 1). In the second scenario, accommodating for increase in vaccination cost by 50% the BCR also declined significantly (Fig 2).